Related content

Applying proteomics to drug discovery

By Stubberfield C.R.   Page M.J.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 1, 1999-01 ,pp. : 65-70

Informa Healthcare

Access to resources Recommend Favorite

The importance of chronobiology to drug discovery

By Farrow Stuart N   Solari Roberto   Willson Timothy M  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 7, 2012-07 ,pp. : 535-541

Informa Healthcare

Access to resources Recommend Favorite

Toxicogenomics in drug discovery and development: mechanistic analysis of compound/class-dependent effects using the DrugMatrix^® database

By Ganter Brigitte   Snyder Ronald D   Halbert Donald N   Lee May D  

Pharmacogenomics, Vol. 7, Iss. 7, 2006-10 ,pp. : 1025-1044

Future Medicine

Access to resources Recommend Favorite

Toxicogenomics in drug safety assessment

By Hewitt Philip   Walijew Alexandra  

Pharmacogenomics, Vol. 9, Iss. 4, 2008-04 ,pp. : 379-382

Future Medicine

Access to resources Recommend Favorite

Future of toxicogenomics and safety signatures: balancing public access to data with proprietary drug discovery

By Fostel Jennifer M  

Pharmacogenomics, Vol. 8, Iss. 5, 2007-05 ,pp. : 425-430

Future Medicine

Access to resources Recommend Favorite